OSTEOARTHRITIS, KNEE
Clinical trials for OSTEOARTHRITIS, KNEE explained in plain language.
Never miss a new study
Get alerted when new OSTEOARTHRITIS, KNEE trials appear
Sign up with your email to follow new studies for OSTEOARTHRITIS, KNEE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Weight loss showdown: surgery vs diet before knee or hip replacement
Disease control TerminatedThis study aimed to see if bariatric surgery or medical weight loss could help severely obese patients (BMI over 40) lose enough weight to safely have hip or knee replacement surgery. Only 3 people joined before the study was stopped early. The goal was to find the best way to lo…
Matched conditions: OSTEOARTHRITIS, KNEE
Phase: NA • Sponsor: Boston Medical Center • Aim: Disease control
Last updated May 17, 2026 04:16 UTC
-
Knee OA drug trial ends early – what happened?
Disease control TerminatedThis study looked at the long-term safety and effectiveness of lorecivivint, an experimental drug for knee osteoarthritis. It enrolled 276 adults who had already completed a previous study. The trial was terminated early, so results are limited. The goal was to see if the drug co…
Matched conditions: OSTEOARTHRITIS, KNEE
Phase: PHASE3 • Sponsor: Biosplice Therapeutics, Inc. • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Tiny nerve zapper eases knee pain without surgery?
Symptom relief TerminatedThis study tested a temporary device that stimulates nerves around the knee to relieve chronic pain from osteoarthritis. Twelve adults with knee pain received the treatment, and researchers measured changes in pain intensity and quality of life. The goal was to see if this non-su…
Matched conditions: OSTEOARTHRITIS, KNEE
Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated May 17, 2026 04:16 UTC
-
Knee pain drug trial halted midway
Symptom relief TerminatedThis study tested an experimental drug called GSK3858279 to see if it could reduce moderate to severe knee pain from osteoarthritis. About 314 adults aged 40 to 80 took part. The trial was stopped early, so we don't have final results on how well the drug worked or its safety.
Matched conditions: OSTEOARTHRITIS, KNEE
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC
-
Knee pain study halted: experimental drug QUC398 falls short
Symptom relief TerminatedThis study tested an experimental drug called QUC398 in 101 people with painful knee osteoarthritis. The goal was to see if it could reduce knee pain and protect knee cartilage. The trial was stopped early, and results are not yet available.
Matched conditions: OSTEOARTHRITIS, KNEE
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated May 11, 2026 20:51 UTC
-
Which X-Ray best spots knee arthritis? study seeks answer
Knowledge-focused TerminatedThis study looked at different X-ray methods to see which best shows arthritis damage in the knee. Researchers compared several X-ray views to MRI and actual tissue samples from knee replacement surgery. The goal was to help doctors choose the right X-ray to decide if a patient n…
Matched conditions: OSTEOARTHRITIS, KNEE
Phase: NA • Sponsor: Oxford University Hospitals NHS Trust • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
Can the 'Love Hormone' ease arthritis pain? small study investigates
Knowledge-focused TerminatedThis study looked at whether oxytocin, a natural hormone, can reduce pain when given through an IV. It included 7 people—some healthy and some with severe knee arthritis. Researchers measured pain from a heated skin patch to see how oxytocin changes pain perception.
Matched conditions: OSTEOARTHRITIS, KNEE
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC